Xenetic Biosciences Inc (XBIO) — Financial Flexibility Index
Xenetic Biosciences Inc (XBIO) has a Financial Flexibility Index of -0.59x as of September 2025. Free cash flow of $-658.24K (operating CF $-658.25K minus capex $3.00) represents -1% of total liabilities ($1.11 Million). Check XBIO PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xenetic Biosciences Inc Financial Flexibility Index (2012–2024)
Historical Financial Flexibility Index trend for Xenetic Biosciences Inc across 13 annual periods. See Xenetic Biosciences Inc (XBIO) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Xenetic Biosciences Inc (2012–2024)
Year-by-year free cash flow to debt coverage for Xenetic Biosciences Inc. For the full company profile including market capitalisation, see Xenetic Biosciences Inc (XBIO) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.15x | $-2.82 Million | $-2.82 Million | $894.26K | ▲ +38.0% |
| 2023 | -5.08x | $-4.11 Million | $-4.11 Million | $809.59K | ▼ -31.5% |
| 2022 | -3.86x | $-4.15 Million | $-4.65 Million | $1.07 Million | ▼ -15.9% |
| 2021 | -3.33x | $-4.74 Million | $-4.74 Million | $1.42 Million | ▲ +24.7% |
| 2020 | -4.43x | $-4.27 Million | $-4.27 Million | $963.97K | ▼ -199.8% |
| 2019 | -1.48x | $-6.40 Million | $-6.40 Million | $4.33 Million | ▼ -3.2% |
| 2018 | -1.43x | $-6.46 Million | $-6.46 Million | $4.52 Million | ▼ -562.7% |
| 2017 | 0.31x | $1.50 Million | $1.49 Million | $4.86 Million | ▲ +116.9% |
| 2016 | -1.83x | $-8.77 Million | $-8.79 Million | $4.80 Million | ▼ -254.8% |
| 2015 | -0.51x | $-5.30 Million | $-5.30 Million | $10.30 Million | ▲ +75.5% |
| 2014 | -2.10x | $-12.27 Million | $-12.33 Million | $5.84 Million | ▼ -141.1% |
| 2013 | -0.87x | $-5.97 Million | $-6.05 Million | $6.85 Million | ▲ +34.7% |
| 2012 | -1.34x | $-6.13 Million | $-6.26 Million | $4.59 Million | — |